Vasomedical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc.

VASO 0.160

0.0%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Michael July who wrote (1355)	9/2/2000 5:12:57 PM
From: Richard James	Read Replies (1) of 1605

Michael, Have to disagree with you about concentrating on beating the bushes for analysts. Management is concentrating on increasing sales and it seems that it has been doing a good job of this. (Believe the size of marketing has been tripled). Not only are new sites opening up at a rate of 3+ week, but new sites include world class institutions (Scripps in California and Ohio's Cleveland Clinic. Believe Texas Heart Institute either is or soon will be on board). In addition to sales to new sites, sales to existing customers should be as much or greater. IMO, the reputation of EECP is quickly moving from snake oil to frontier therapy to a standard cardiology procedure. If quarterly numbers show what I expect, the price will be nice. Richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next